Coronary Restenosis
📧 Sign up to get email alerts when something new happens for Coronary Restenosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-05-13Clinical Trial Update: XIENCE V: SPIRIT WOMEN [Phase 4]
This is a Phase 4 clinical trial update for XIENCE V in the SPIRIT WOMEN study, which has completed. The trial evaluated outcomes of the XIE…
-
CLINICAL_TRIALS trial_result · 2015-02-06Clinical Trial Update: The ASSURE ROT Registry: Bioresorbable Vascular Scaffold Following Rotablation for Complex Coronary Lesions
This is a ClinicalTrials.gov registry entry for the ASSURE ROT Registry evaluating a bioresorbable vascular scaffold after rotablation for c…
-
CLINICAL_TRIALS trial_result · 2014-10-13Clinical Trial Update: EGO-COMBO Clinical End-point Extension Study Beyond 36 Months
Clinical trial update indicates the EGO-COMBO endpoint extension study for coronary restenosis has extended beyond 36 months and is reported…
-
CLINICAL_TRIALS trial_result · 2014-01-03Clinical Trial Update: A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coronary Stent System in Japanese Population [NA]
A completed clinical trial evaluated the XIENCE PRIME Small Vessel Everolimus Eluting Coronary Stent System in a Japanese population. Result…
-
CLINICAL_TRIALS trial_result · 2013-10-11Clinical Trial Update: XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort)
This is a USA post-approval long-term follow-up study of the XIENCE V everolimus-eluting coronary stent system; results were posted in 2013.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: OCT Evaluation of Healing of COMBO Stent [Phase 1, Phase 2]
This update reports completion of Phase 1/2 trials evaluating healing with the COMBO Stent using OCT imaging.
-
CLINICAL_TRIALS trial_result · 2013-02-26Clinical Trial Update: Optical Coherence Tomography to Evaluate Paclitaxel-Eluting Balloons and Everolimus-Eluting Coronary Stents [Phase 4]
Phase 4 trial evaluating paclitaxel-eluting balloons and everolimus-eluting coronary stents using optical coherence tomography; the study ha…
-
CLINICAL_TRIALS trial_result · 2012-12-24Clinical Trial Update: The SCRIPPS DES REAL WORLD Registry
The SCRIPPS DES REAL WORLD Registry clinical trial, sponsored by Paul S Teirstein, MD, has completed, involving coronary artery disease, cor…
-
CLINICAL_TRIALS trial_result · 2012-12-04Clinical Trial Update: EXCEL Clinical Trial (Universal Registry)
An update indicating the EXCEL trial comparing PCI with everolimus-eluting stents to CABG for left main coronary artery disease has complete…
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implanted in the Treatment of Restenosis in Non-coated Metallic Stent (BMS In-stent Restenosis) During a 2 Year Clinical Follow-up Period [Phase 3]
Phase 3 study evaluating the safety and efficacy of the everolimus-eluting Xience V stent for treating in-stent restenosis of a bare-metal s…
-
CLINICAL_TRIALS trial_result · 2012-08-14Clinical Trial Update: XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-arm Study
A post-marketing, single-arm clinical study in India evaluating the XIENCE V Everolimus-eluting coronary stent system has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-13Clinical Trial Update: XIENCE V: SPIRIT WOMEN Sub-study [Phase 4]
Phase 4 SPIRIT WOMEN sub-study updating results for the XIENCE V everolimus-eluting coronary stent; the study completed with results posted …
-
CLINICAL_TRIALS trial_result · 2012-06-01Clinical Trial Update: SPIRIT PRIME Clinical Trial [Phase 3]
Abbott Medical Devices has completed and posted results for the SPIRIT PRIME Phase 3 clinical trial.
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis [Phase 1, Phase 2]
A Phase 1/2 trial evaluating ABI-007, a nanoparticle paclitaxel formulation, for prevention of in-stent restenosis in coronary arteries; the…
-
CLINICAL_TRIALS trial_result · 2012-01-10Clinical Trial Update: Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries [Phase 2]
A Phase 2 trial evaluating the safety and efficacy of the ZoMaxx Drug-Eluting Stent System in coronary arteries has completed.
-
CLINICAL_TRIALS trial_result · 2011-11-22Clinical Trial Update: Is There A LIfe for Drug Eluting Stent (DES) After Discontinuation of Clopidogrel
A clinical trial examining the outcomes of using drug-eluting stents after discontinuation of clopidogrel in patients with restenosis; no pu…
-
CLINICAL_TRIALS trial_result · 2011-07-20Clinical Trial Update: SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System [Phase 3]
A Phase 3 clinical trial (SPIRIT II) evaluating the XIENCE V Everolimus-eluting coronary stent system has completed.
-
CLINICAL_TRIALS trial_result · 2011-04-15Clinical Trial Update: Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty [Phase 4]
A Phase 4 trial update on post-PCI cardiac imaging in patients with Type 2 diabetes mellitus has completed. The study aims to detect coronar…
-
CLINICAL_TRIALS trial_result · 2011-04-01Clinical Trial Update: Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries [Phase 2, Phase 3]
Phase 2/Phase 3 trial update reporting on the safety and efficacy of the ZoMaxx drug-eluting stent system in coronary arteries, with the tri…
-
CLINICAL_TRIALS trial_result · 2010-10-21Clinical Trial Update: SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study) [Phase 4]
Phase 4 diabetic sub-study evaluating the XIENCE V everolimus-eluting coronary stent system in de novo coronary lesions; results have been p…
-
CLINICAL_TRIALS trial_result · 2010-10-14Clinical Trial Update: SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe [Phase 4]
A post-marketing Phase 4 study evaluating the XIENCE V Everolimus Eluting Coronary Stent System in Europe has completed.
-
CLINICAL_TRIALS trial_result · 2010-08-06Clinical Trial Update: Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis [Phase 2, Phase 3]
A completed randomized trial evaluated the slow-release TAXUS paclitaxel-eluting coronary stent for treating in-stent restenosis.
-
CLINICAL_TRIALS trial_result · 2009-08-20Clinical Trial Update: Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents [Phase 4]
Phase 4 trial comparing oral sirolimus (rapamycin) with bare-metal stents versus drug-eluting stents in coronary disease; results posted in …
-
CLINICAL_TRIALS trial_result · 2009-06-23Clinical Trial Update: Numen Stent Assessment Using OCT Technique in a Single Center Study [Phase 2, Phase 3]
Clinical trial update on the Numen Stent in a single-center Phase 2/Phase 3 study using OCT imaging to assess restenosis-related hyperplasia…
-
CLINICAL_TRIALS trial_result · 2009-03-10Clinical Trial Update: Oral Sirolimus for In-Stent Restenosis [Phase 4]
Phase 4 trial of oral sirolimus for preventing in-stent restenosis in patients with coronary restenosis has completed.